Log in to your Inderes Free account to see all free content on this page.
Subgen AI
0.29 SEK
+3.62 %
Less than 1K followers
SUBGEN
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Subgen AI
P/B
Median 2020-2024
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share price (SEK) | 2,621.62 | 6,911.10 | 265.28 | 154.34 | 12.00 |
| Shares | 0.1 | 0.1 | 0.1 | 0.2 | 0.4 |
| Market cap | 364.6 | 961.2 | 38.6 | 29.3 | 5.2 |
| Enterprise value | 354.9 | 928.6 | - | - | - |
| EV/S | - | 69.9 | - | - | - |
| EV/EBITDA | neg. | neg. | - | - | - |
| EV/EBIT | neg. | neg. | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. |
| P/B | 7.79 | 2.60 | 0.12 | -20.22 | -0.13 |
| P/S | - | 72.4 | 22.6 | 325.7 | - |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 89.9 % | 91.6 % | 92.5 % | -2.7 % | -118.5 % |
| Gearing ratio | 1.5 % | 0.4 % | 0.7 % | -2,256.6 % | -113.9 % |
Login required
This content is only available for logged in users